Risk-MaPP: What is it and Why You Need it!

by Madjackfrost on June 17, 2010

Description

With the use of multi-product facilities, the risk of cross contamination increases. By properly managing the risk of cross contamination manufacturers can reap the benefit of lower cost and higher efficiency while maintaining product quality and patient safety. Gain a basic understanding of why this guide is important to you and what you can do to manage the risk of cross contamination.

The much anticipated release of ISPE’s New Baseline Guide®, Risk-MaPP, provides a scientific, risk-based methodology approach, based on ICH Q9, to manage the risk of cross contamination in order to achieve and maintain an appropriate balance between product quality and operator safety. With the use of multi-product facilities, the risk of cross contamination increases. By properly managing the risk of cross contamination manufacturers can reap the benefit of lower cost and higher efficiency while maintaining product quality and patient safety. Gain a basic understanding of what this guide is and why it is important to you.
Related Information

This information will provide a good foundation for the upcoming conferences in Brussels and Washington, DC (Attendees will receive a FREE copy of the Guide with paid registration); Tokyo; Singapore; and Orlando, Florida, USA. For more information visit our Risk-MaPP Resource site.

Cost

Members*: $79  NonMembers: $179

*Become an ISPE Member and start taking advantage of the many membership benefits, including deep discounts on all ISPE Online Learning programs.
Registration http://www.ispe.org/onlinelearning/whyriskmappimportant

Live Webinar Icon
14 September 2010, 11.00 EDT
(Time Zone Converter)
60 Minutes
Members: $79
Nonmembers: $179
Fundamental course level
A recorded version of this event will be available for purchase within 5 business days of the live event.

Join hundreds of students and get all book resources for FREE! Subscribe to Pharmacy E-books via RSS or via E-mail

Leave a Comment

*

Previous post:

Next post: